Human immunodeficiency virus (HIV) remains a global health challenge ... However, current nucleic acid tests (NATs) often require advanced laboratory infrastructure and trained personnel, making ...

For retroviruses in general, viral nucleic acids seem to access the nucleus during mitosis. In contrast, lentiviruses such as human immunodeficiency virus (HIV) do not depend on host cell mitosis ...

European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2 ...

The global HIV diagnostics market, valued at US$2.96B in 2024, is forecasted to grow at a 10.3% CAGR, reaching US$3.25B by 2025 and US$5.31B by 2030.

Speaking at the event organised at Government Nursing Training School, the Collector said that TB remained a significant health concern. In order to diagnose and treat the disease more effectively, ...

New York, USA, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Global Nucleic Acid Amplification Testing Market to Grow Rapidly at an ~8% CAGR by 2032 | DelveInsight The growing demand for nucleic acid ...

Increasing incidence of genetic disorders, cancer, and infectious diseases like COVID-19, HIV, and hepatitis is driving demand ... and precision diagnostics is driving the use of nucleic acid-based ...